Cipla shareholding pattern

·Pharma & HealthChart ›

Who owns itSep 2026 quarter

Promoters29.21%no change
Foreign investors (FII)20.25%+0.04 pts
Domestic institutions (DII)34.94%+0.31 pts
of which mutual funds20.78%+0.22 pts
of which insurance companies11.69%
Public15.60%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CIPLA₹1,365.60

Cipla Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMADRREDDYLUPINAPOLLOHOSPMAXHEALTHDIVISLABTORNTPHARMZYDUSLIFEMcap ₹1.10L Cr
Holding % of Total Shares
12 Months Ending
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Promoter & Group30.9130.9229.1929.2029.1929.2129.2129.2129.2129.21
FII / FPI27.8128.8026.6526.2825.2524.5523.9322.5620.2120.25
DII24.9524.1627.7128.1529.2630.2530.7231.9734.6334.94
Mutual Funds17.6217.4820.4620.5120.4420.2319.2118.6620.5620.78
Latest: 2026-09-30 · 61 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.